Showing results (1891-1900 of 2,086) with videos related to
Sort By:
Pageof 209
Nature Communications|May 28, 2014
Fabrication of crystals from single metal atomsNicolas P E Barry, Anaïs Pitto-Barry, Ana M Sanchez, et al.Journal of Hepatology|May 1, 1996
Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patientsP Simmonds, J Mellor, A Craxi, et al.Biological Psychiatry|September 10, 2025
RNA in Plasma Extracellular Vesicles of Adolescent Rhesus Macaques Reveal Immune, Bioenergetic, and Microbial Imprints of Early-Life Adversity: An Exploratory AnalysisLaura Korobkova, Matthew E Thornton, Matthew A Collin, et al.Hepatology (Baltimore, Md.)|September 22, 2012
Inhibition of RelA-Ser536 phosphorylation by a competing peptide reduces mouse liver fibrosis without blocking the innate immune responseAnna Moles, Ana M Sanchez, Paul S Banks, et al.Stem Cell Research & Therapy|April 16, 2026
Comparative analysis of NSG and NBSGW mice for preclinical evaluation of gene-modified human hematopoietic stem and progenitor cellsCaroline Y Kuo, Sean Harrington, Beatriz Campo-Fernandez, et al.Nature Structural & Molecular Biology|April 5, 2011
Single-molecule paleoenzymology probes the chemistry of resurrected enzymesRaul Perez-Jimenez, Alvaro Inglés-Prieto, Zi-Ming Zhao, et al.Scientific Reports|November 22, 2016
Realisation of magnetically and atomically abrupt half-metal/semiconductor interface: Co2FeSi0.5Al0.5/Ge(111)Zlatko Nedelkoski, Balati Kuerbanjiang, Stephanie E Glover, et al.Experimental Hematology|July 26, 2005
Posttransplant hematopoiesis in patients undergoing sibling allogeneic stem cell transplantation reflects that of their respective donors although with a lower functional capabilityFermin M Sanchez-Guijo, Luis-Ignacio Sanchez-Abarca, Eva Villaron, et al.Biomaterials Science|April 20, 2023
Personalized tissue-engineered veins - long term safety, functionality and cellular transcriptome analysis in large animalsKlas Österberg, Yalda Bogestål, Lachmi Jenndahl, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 15, 2014
Randomized, phase III trial of figitumumab in combination with erlotinib versus erlotinib alone in patients with nonadenocarcinoma nonsmall-cell lung cancerG V Scagliotti, I Bondarenko, F Blackhall, et al.Pageof 209